QA: Rezolute Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2023_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001509261, Rezolute Inc.

  xvar xval
0 AssetsCurrent 152,104,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 16,000
3 remainder_Assets 300,000
4 LiabilitiesCurrent 2,462,000
5 LiabilitiesNoncurrent 80,000
6 remainder_Liabilities 407,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,357,000
9 ResearchAndDevelopmentExpense 32,486,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 783,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 152,420,000
1 Liabilities 2,949,000
2 Expenses 41,843,000
3 Revenues 0
4 StockholdersEquity 149,471,000
5 NetIncome -41,060,000
6 ComprehensiveNetIncome -41,060,000
7 BaseVar 98,997,500
8 EconomicCapitalRatio 2.78

Edgar->Model Mapping

Feature Distribution

Change over Time